Proteome Sciences plc (LON:PRM – Get Free Report) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 4.07 ($0.05) and traded as low as GBX 3.55 ($0.05). Proteome Sciences shares last traded at GBX 3.86 ($0.05), with a volume of 364,200 shares trading hands.
Proteome Sciences Price Performance
The stock has a market cap of £11.39 million, a P/E ratio of -386.00 and a beta of -0.03. The company has a fifty day moving average of GBX 3.70 and a 200 day moving average of GBX 4.07.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- Financial Services Stocks Investing
- Sarepta Therapeutics Stock Soars on FDA Approval
- What is the Australian Securities Exchange (ASX)
- CarMax: A Market Melt-Up Waiting to Happen for this Stock
- Stock Analyst Ratings and Canadian Analyst Ratings
- 3 Solar Stocks to Watch that are Building the Green Energy Future
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.